Background Tuberculosis is a bacterial infectious disease, which affects different parts of a
human body, mainly lungs and can lead to the patient's death. The aim of this study is to …

Background Multidrug-resistant tuberculosis (MDR-TB) in HIV infected individuals is a
serious threat to global efforts to combat tuberculosis. Inconsistent findings on the …

India accounts for about one-fourth of the global burden of MDR-TB. This study aims to
assess the prevalence and factors associated with tuberculosis drug resistance among …

Rationale: High-dose isoniazid is recommended in short-course regimens for multidrug-
resistant tuberculosis (TB). The optimal dose of isoniazid and its individual contribution to …

Drug-resistant tuberculosis: advances in diagnosis and manag... : Current Opinion in
Pulmonary Medicine Drug-resistant tuberculosis: advances in diagnosis and management …

Background Multidrug-resistant tuberculosis (MDR-TB) has continued to be a serious public
health threat and significantly challenges global TB control and prevention efforts, where the …

Background Tuberculosis (TB) is among the top 10 causes of mortality and the first killer
among infectious diseases worldwide. One of the factors fuelling the TB epidemic is the …

We reviewed the records of 337 confirmed cases of tuberculosis patients in Monrovia, the
capital of Liberia, 2015. The risk factors affecting the survival and multidrug-resistance of …

Background Tuberculosis (TB) remains a pressing public health challenge, with multidrug-
resistant tuberculosis (MDR-TB) emerging as a major threat. And healthcare authorities …

Background Multidrug-resistant tuberculosis (MDR-TB) is another problem in TB elimination.
In 2018, 484,000 people worldwide developed tuberculosis that was resistant to rifampicin …